An Illinois federal court enters a permanent injunction against three related firms to stop them from selling adulterated and misbranded dietary suppl...
FDA accepts for review an EMD Serono NDA resubmission for cladribine tablets for treating patients with relapsing forms of multiple sclerosis.
FDA approves Medtronics Implantable System for Remodulin for treating patients with pulmonary arterial hypertension.
FDA releases its latest batch of Warning Letters that include Anigan, Milbar Laboratories and Yuki Gosei.
FDA approves an Integer Holdings PMA for its radial access introducer RadialSeal.
FDA publishes the biosimilar user fee schedule for FY 2019.
FDA increases the list of drug repackagers recalling some valsartan-containing products.
FDA cautions against using energy-based medical devices for vaginal rejuvenation or cosmetic vaginal procedures.